Abel Hall LLC’s Caribou Biosciences CRBU Stock Holding History

Abel Hall LLC’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$26.5K	Buy	+20,890	New	+$32.6K	﹤0.01%	863

Other funds holding CRBU

Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return

MAM

Milestone Asset Management Pittsburgh, Pennsylvania $631M AUM 19.95% 1-Year Est. Return

Prime Capital Investment Advisors Overland Park, Kansas $10.2B AUM 17.74% 1-Year Est. Return

Thrive Wealth Management Audubon, Pennsylvania $805M AUM 17.78% 1-Year Est. Return

Axxcess Wealth Management Carlsbad, California $2.44B AUM 16.42% 1-Year Est. Return

Sax Wealth Advisors Parsippany, New Jersey $3.5B AUM 13.72% 1-Year Est. Return

Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.71B AUM 23.29% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Abel Hall LLC's CRBU Position: Q3 2026 in Review

Abel Hall LLC opened a new position in Caribou Biosciences (CRBU) in Q3 2026: 20,890 shares worth $26.5K. The stake represents ﹤0.01% of the portfolio and ranks #863 among its holdings.

25 funds tracked by Wall St. Rank hold CRBU as of Q3 2026.

Abel Hall LLC held 20,890 shares of Caribou Biosciences worth $26.5K as of Q3 2026.
Caribou Biosciences was a new Abel Hall LLC position in Q3 2026.
Caribou Biosciences made up ﹤0.01% of Abel Hall LLC's portfolio in Q3 2026, its #863 holding.
25 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.